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ABSTRACT 
As techniques and device technology have improved, the success rates and long patency of ilio-femoral occlusive 
disease have also improved. In the case of extensive iliac occlusive disease, however, wire passage and handling re-
main a challenge due to the relatively weak guiding catheter backup support with the contralateral femoral ap-
proach. There has been no report on methods to overcome this problem. We performed a successful percutane-
ous translunimal angioplasty for long ilio-femoral occlusive disease including the iliac ostium by a dual approach 
including simultaneous brachial and contralateral femoral arteries for subintimal angioplasty. (Korean Circ J 2010; 
40:90-93) 
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Introduction 
 
When performing a percutaneous transluminal an-
gioplasty (PTA) for common iliac artery (CIA) occlusive 
lesions involving the ostium, we usually experience dif-
ficulty in passage or handling of the wire due to the re-
latively weak guiding catheter backup support with the 
contralateral femoral approach. Furthermore, in situa-
tions involving a very long ilio-femoral artery, it is very 
difficult to finalize the procedure because of practical li-
mitations including a short balloon length and diffi-
culty with wire manipulation. Here we present a dual ap-
proach including simultaneous brachial and contrala-
teral femoral arteries for subintimal angioplasty in a pa-
tient with long ilio-femoral occlusive disease including 
the iliac ostium. 
 
Case 
 
A 79-year-old man was admitted to our hospital due 
to necrosis of the left third toe, anterior tibial ulcera-
tion, and claudication (Fontaine IV). Symptoms deve-
loped one year ago, and the patient’s clinical status has 
deteriorated over the past week. The patient was treat-
ed for pulmonary tuberculosis 20 years ago; however, 
his sputum acid-fast bacilli stain continues to be posi-
tive. He was a current smoker with a 20-pack-year his-
tory. The chest X-ray showed significant lung volume 
reduction due to tuberculosis related destruction. The 
echocardiography showed a left ventricular ejection frac-
tion of 35% with global hypokinesia. The coronary an-
giography revealed insignificant stenosis. Computed 
tomography-angiography (CTA) of the lower extremities 
showed total occlusion from the left CIA ostium to the 
distal femoral artery with a reasonably collateralized cir-
culation (Fig. 1A). The ankle-brachial index was zero 
for the left side, and 0.97 for the right side.   
Because of the high risk of general anesthesia and pa-
tient refusal to undergo surgical revascularization, endo-
vascular treatment was planned for the extensive ilio-
femoral occlusive disease. The antegrade approach from 
the contralateral common femoral artery was not pos-
sible due to the iliac ostium lesion, as shown in the CTA 
of the lower extremity. Lower limb angiography, there-
fore, was performed via the right brachial artery with a 
Received: July 19, 2009 
Accepted: September 9, 2009 
Correspondence: Weon Kim, MD, Division of Cardiology, Department of
Internal Medicine, Kyung Hee University Medical Center, 1 Hoegi-dong,
Dongdaemun-gu, Seoul 130-702, Korea 
Tel: 82-2-958-8170, Fax: 82-2-958-8160 
E-mail: mylovekw@hanmail.net 
 
○  cc This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,
distribution, and reproduction in any medium, provided the original work is
properly cited.  
 
Jong Shin Woo, et al.·91 
six French shuttle sheath. The angiography revealed to- 
tal occlusion of left CIA and left common femoral ar-
tery with collateral flow that reconstructed the distal 
superficial femoral artery (SFA) (Fig. 2A). Using a 0.035 
inch angled Terumo wire with a backup catheter (4F 
multipurpose catheter, Merit Medical, South Jordan, 
Utah, USA), successful wiring from the CIA to the ex-
ternal iliac artery was performed by subintimal wire 
tracking without significant dissection (Fig. 2B). The 
iliac artery lesion was predilated with a 6.0×40 mm 
balloon (10 atm, Powerflex, Cordis, Bridgewater, NJ, 
USA) (Fig. 2C). After predilation, subintimal dye st-
aining was noted. A six French Balkin sheath was in-
serted through the contralateral femoral artery (Fig. 3A), 
and a 0.035 inch angled Terumo wire was successfully 
passed through the SFA by the transfemoral approach 
(Fig. 3B). A 10.0×60 mm peripheral self-expandable 
stent (Smart, Cordis) was deployed in the CIA to the 
external iliac artery (Fig. 3C). After post-dilatation with 
an 8.0×40 mm balloon (10 atm, Powerflex, Cordis) in 
the CIA to the external iliac artery, an 80% diffuse ir-
regular stenosis at the proximal SFA was noted. Predi-
latation was performed with a 4.0×40 mm, and 5.0×
40 mm (10 atm, Powerflex, Cordis) balloon; however, 
residual stenosis was present at about 60% or more. 
The pressure gradient (50 mmHg) remained at the fe-
moral head area with dissection in spite of the addi-
tional ballooning using the 5.0×80 mm balloon (10 
atm, Powerflex, Cordis). Then, a 7.0×40 mm self-ex-
pandable stent (Smart, Cordis) was deployed in the SFA 
and additional ballooning was performed using a 5.0
×80 mm (10 atm, Powerflex, Cordis) for the CIA and 
SFA (Fig. 3D). The final angiography showed patent 
stents with good distal flow (Fig. 4), and the pressure 
gradient between the CIA and popliteal artery was less 
than 10 mmHg.   
The follow up CTA showed no residual stenosis from 
the CIA to the distal femoral artery (Fig. 1B). The pa-
tient had no residual symptoms and the left ankle-bra-
chial index was improved to 0.96 after the successful 
angioplasty.  
 
Discussion 
 
The TransAtlantic InterSociety Consensus (TASC) 
statement in 1999 provided a framework for clinicians 
to use to assess the treatment of aortoiliac and femoral 
lesions in the peripheral vasculature by stratifying the 
lesion length and morphology.
1) At the time of that pu- 
Fig. 1. Computed tomography-angiography (CTA) of the lower
extremity. (A) shows total occlusion from the left common iliac
artery ostium to the distal femoral artery with a reasonably col-
lateralized circulation; after percutaneous transluminal angio-
plasty, the follow-up CTA revealed no residual stenosis from the
common iliac artery to the distal femoral artery as shown in (B).
A  B 
Fig. 2. Subintimal wiring for iliac occlusion through right brachial artery. Lower limb angiography via the right brachial artery revealed
total occlusion of the left common iliac artery and left common femoral artery with collateral flow that reconstructed the distal superficial
femoral artery as shown in (A). Using a 0.035 inch angled Terumo wire with a backup catheter; successful wiring from the common iliac
artery to the external iliac artery was performed by subintimal wire tracking as shown in (B). After predilation (C), subintimal dye staining
was noted as shown in (D). 
A  B  C D  
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blication, the available data suggested that most iliac 
occlusions should be treated with surgical revasculari-
zation. Most articles about bypass surgery were written 
in the 1970s and 1980s, before endovascular therapy 
began to replace open reconstruction.
2) The endovas-
cular treatment of ilio-femoral occlusive disease has evolv-
ed over the last two decades. As CTA imaging, balloon 
angioplasty, stent technology, and endovascular techni-
ques have improved, success rates and long patency of 
ilio-femoral occlusive disease has also improved. 
In patients with extensive iliac occlusive disease, open 
revascularization is the treatment of choice in current 
vascular surgical practice, according to the TASC state-
ment.
1) Surgical revascularization, however, also has the 
risks associated with general anesthesia, and cannot be 
performed in all patients. Recent reports have shown a 
decreasing number of patients undergoing aorto-bife-
moral bypass.
3)4) In addition, endovascular procedures 
are often used as first-line therapy for aortoiliac occlu-
sive disease; this is because many believe that surgical 
options are available if the endovascular therapy is un-
successful. PTA has the additional advantage in that it 
can be performed without hemodynamic changes. Ka-
shyap et al.
5) compared bypass surgery with PTA. In this 
report, there was no significant difference in the se-
condary patency rates, limb salvage, and long-term sur-
vival between the two groups. The patients undergoing 
PTA with TASC-D lesions tended to have better pat-
ency. Several studies have documented the outcomes 
of treatment of more complex iliac occlusions of the 
TASC-C and TASC-D. Several studies have shown that 
the primary patency ranged from 69% to 76% at 2 
years, with the secondary patency rates of 85% to 95% 
at 2 years.
6-9) Furthermore, the overall complication rates 
were reported to be low in a recent series (1.4-4.8%), 
likely because of improvements in technique and device 
technology.  
The most common techniques used for recanaliza-
tion of iliac ostium occlusive disease are usually perform-
ed with a retrograde approach from the ipsilateral com-
mon femoral artery or popliteal artery, an antegrade 
approach from the left brachial artery, or an antegrade 
approach from the contralateral CIA. In some cases, 
PTA has been performed successfully by using devices 
designed for coronary intervention.
10) However, in si-
tuations involving a very long ilio-femoral artery, pa-
tients require multiple access sites for successful treat-
ment, because of practical limitations including short 
balloon length. For a successful PTA, not only device 
technology but also specialized backup supports are 
A  B  C D 
Fig. 3. Subintimal wiring for superficial femoral artery occlusion via the contralateral femoral artery. A six French Balkin sheath was in-
serted through the contralateral femoral artery (A), and a 0.035 inch angled Terumo wire was successfully passed through the superficial
femoral artery by the antegrade approach via the right femoral artery (B). A 10.0×60 mm peripheral self-expandable stent (Smart,
Cordis) was deployed in the common iliac artery to the external iliac artery (C). Percutaneous transluminal angioplasty for the common
iliac artery and superficial femoral artery was carried out (D). 
Fig. 4. Final angiography. After percutane-
ous transluminal angioplasty, patent stents
with good distal flow were noted.  
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needed. We performed a successful PTA in a patient 
with long ilio-femoral occlusive disease that included 
the iliac ostium by a dual approach. The PTA was car-
ried out at the iliac ostial lesion via the antegrade ap-
proach from the right brachial artery. After recanaliza-
tion of the iliac ostium, the ilio-femoral lesion was tr-
eated by the antegrade approach from the contralateral 
femoral artery. Using this dual approach, we could per-
form successful endovascular treatment by virtue of the 
good backup support.   
Although this report relates to only one patient, in 
certain situations where both contralateral femoral and 
ipsilateral popliteal access is difficult because of con-
comitant vascular disease or variation in anatomy, the 
dual approach technique of simultaneous brachial and 
contralateral femoral artery access may broaden the 
endovascular therapeutic possibilities for treatment of 
long ilio-femoral occlusive disease including the iliac 
ostium. 
In conclusion, the dual approach technique of simul-
taneous brachial and contralateral femoral artery ac-
cess enabled treatment of total occlusive lesions asso-
ciated with long ilio-femoral occlusive disease, includ-
ing the iliac ostium, without significant complications. 
PTA should be considered as the first choice for a re-
vascularization procedure; it is safe and effective for 
limb salvage in patients with critical limb ischemia. 
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